Decrypting the dynamics of continuing conflict in eastern Democratic Republic of Congo (DRC) is challenging at the best of times, more so given the profound political uncertainty that currently reigns at the national level.
West Africa is still paying the price for its poor response to the Ebola epidemic. Where an early response could have prevented the worst, failures on all levels allowed Ebola to spread, exposing a deep rift between the population and political class of the countries affected. Unless all actors learn from the crisis, a similar disaster may be just a matter of time.
Over the past ten years, Médecins Sans Frontières (MSF) has provided medical care to almost 118,000 victims of sexual violence. Integrating related care into MSF general assistance to populations affected by crisis and conflicts has presented a considerable institutional struggle and continues to be a challenge. Tensions regarding the role of MSF in providing care to victims of sexual violence and when facing the multiple challenges inherent in dealing with this crime persist.
As part of International Humanitarian Law (IHL), Additional Protocols I and II of 1977 to the Geneva Conventions and other treaties provide for the protection of patients, medical personnel and health infrastructures during armed conflicts. They recognize the primacy of medical ethics in times of war, notably the principle of non-discrimination. Attacks against hospitals or health care providers during armed conflicts signal a blatant disregard for such protections. A state of affairs where IHL is ignored, denied or revisited has far-reaching consequences for the medical profession.
Overseas development agencies and international finance organisations view the exploitation of minerals as a strategy for alleviating poverty in low-income countries. However, for local communities that are directly affected by extractive industry projects, economic and social benefits often fail to materialise. By engaging in Corporate Social Responsibility (CSR), transnational companies operating in the extractive industries ‘space’ verbally commit to preventing environmental impacts and providing health services in low-income countries.
Chiara Lepora and Robert Goodin invite us to join their insightful ‘conversation’ on complicity and compromise. Their book makes a dense, utterly precise and rewarding reading, as one proceeds stepwise through the logic of their philosophical arguments. For those unfamiliar with the relatively new discipline of ‘humanitarian ethics’, it might be disconcerting at first to see humanitarian actions brought to illustrate theories on complicity, with the Rwandan refugees crisis of 1994 and the tortured patient taken as two exemplary cases.
We challenge the assertion made by Govind Persad and Ezekiel Emanuel (Aug 27, p 932) that “expanding access to less effective or more toxic [antiretroviral] treatments rather than requiring the worldwide best treatment in all settings” is ethically justifiable.
On Oct 10, 2015, Médecins Sans Frontières (MSF) rejected Pfizer's proposed donation of 1 million doses of its branded pneumococcal conjugate vaccine (PCV). The news caused a stir in the global health community; after all, free essential health goods might be considered something to be celebrated.
Palliative care interventions have historically been neglected in the practice of humanitarian medicine. This may come as a surprise, since it is a sombre reality that medical practitioners are frequently witness to death and dying in their response to humanitarian crises.
The West African Ebola epidemic has set in motion a collective endeavour to conduct accelerated clinical trials, testing unproven but potentially lifesaving interventions in the course of a major public health crisis. This unprecedented effort was supported by the recommendations of an ad hoc ethics panel convened in August 2014 by the WHO.